Search Results - hyungdae+jin

3 Results Sort By:
Apparatus and Method for continuous Production of Semiconductor Nanoparticles
A continuous-flow injection reactor and a method for continuous material synthesis, including synthesis of nanoparticles Background Nanocrystalline semiconductors have attracted a considerable amount of attention due to their unique physiochemical properties. Recent advances in nanocrystals are having a dramatic impact on the development of next...
Published: 10/15/2024   |   Inventor(s): Chih-hung Chang, Hyungdae Jin, Yu-Wei Su
Keywords(s): Advanced Technology and Manufacturing Inst. (ATAMI), Chemicals / Chemical Engineering, Electrical & Computer Engineering, Nanotechnology
Category(s): Chemical, Chemistry, Engineering, Nanoscience & Microtechnologies, Device, Materials Science, Physical Science
Inhibition of T Cell Differentiation and Senescence by Overexpression of Transcription Factor c-Myb
Abstract: Adoptive Cell Therapy (ACT) is a promising technique that uses a patient's own T cells to treat cancer. The process requires removing and engineering a patient's T cells to express a chimeric antigen receptor (CAR) or T cell receptor (TCR) that targets a specific cancer antigen. When the modified T cells are reintroduced into the patient,...
Published: 4/8/2024   |   Inventor(s): Sanjivan Gautam, Yun Ji, Luca Gattinoni
Keywords(s): act, Adoptive Cell Transfer, CANCER, CAR, chimeric antigen receptor, Gattinoni, Immunotherapy, Infectious Disease, Stem Cell, T cell, T Cell Receptor, TCR
Category(s): Collaboration Sought > Collaboration, Application > Therapeutics, TherapeuticArea > Oncology, Collaboration Sought > Licensing
Overexpression of Phf19 on T Cells Enhances Therapeutic Effects of T Cell-Based Therapies (such as Chimeric Antigen Receptor [CAR] Therapies)
Abstract: T cell-based immunotherapy (such as CAR therapies) is a promising approach for the treatment of several cancers. However, T cells currently employed for various T cell-based immunotherapies are usually senescent and terminally differentiated leading to poor proliferative and survival capacity, limiting their therapeutic effectiveness once...
Published: 4/8/2024   |   Inventor(s): Yun Ji, Luca Gattinoni
Keywords(s): CAR-T Therapy, CD8, chimeric antigen receptor, Gattinoni, Phf19, T cell
Category(s): TherapeuticArea > Oncology, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics